1. Home
  2. LRMR vs BSVN Comparison

LRMR vs BSVN Comparison

Compare LRMR & BSVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LRMR
  • BSVN
  • Stock Information
  • Founded
  • LRMR N/A
  • BSVN 2004
  • Country
  • LRMR United States
  • BSVN United States
  • Employees
  • LRMR N/A
  • BSVN N/A
  • Industry
  • LRMR Biotechnology: Pharmaceutical Preparations
  • BSVN Major Banks
  • Sector
  • LRMR Health Care
  • BSVN Finance
  • Exchange
  • LRMR Nasdaq
  • BSVN Nasdaq
  • Market Cap
  • LRMR 332.1M
  • BSVN 393.6M
  • IPO Year
  • LRMR N/A
  • BSVN 2018
  • Fundamental
  • Price
  • LRMR $3.45
  • BSVN $41.13
  • Analyst Decision
  • LRMR Strong Buy
  • BSVN Buy
  • Analyst Count
  • LRMR 7
  • BSVN 3
  • Target Price
  • LRMR $16.71
  • BSVN $53.33
  • AVG Volume (30 Days)
  • LRMR 1.8M
  • BSVN 14.5K
  • Earning Date
  • LRMR 11-05-2025
  • BSVN 10-15-2025
  • Dividend Yield
  • LRMR N/A
  • BSVN 2.34%
  • EPS Growth
  • LRMR N/A
  • BSVN 19.43
  • EPS
  • LRMR N/A
  • BSVN 4.54
  • Revenue
  • LRMR N/A
  • BSVN $95,710,000.00
  • Revenue This Year
  • LRMR N/A
  • BSVN N/A
  • Revenue Next Year
  • LRMR N/A
  • BSVN $2.23
  • P/E Ratio
  • LRMR N/A
  • BSVN $9.03
  • Revenue Growth
  • LRMR N/A
  • BSVN 11.45
  • 52 Week Low
  • LRMR $1.61
  • BSVN $32.49
  • 52 Week High
  • LRMR $9.50
  • BSVN $50.26
  • Technical
  • Relative Strength Index (RSI)
  • LRMR 39.35
  • BSVN 34.37
  • Support Level
  • LRMR $3.16
  • BSVN $40.71
  • Resistance Level
  • LRMR $4.50
  • BSVN $42.37
  • Average True Range (ATR)
  • LRMR 0.30
  • BSVN 0.83
  • MACD
  • LRMR -0.10
  • BSVN -0.00
  • Stochastic Oscillator
  • LRMR 24.09
  • BSVN 28.25

About LRMR Larimar Therapeutics Inc.

Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.

About BSVN Bank7 Corp. Common stock

Bank7 Corp is a full-service commercial bank focused on providing customers with exceptional service and meeting their banking needs through a variety of commercial and retail financial services. It offers deposit banking products, including commercial deposit services, commercial checking, money market, and other deposit accounts, and retail deposit services such as certificates of deposit, money market accounts, checking accounts, negotiable order of withdrawal accounts, savings accounts, and automated teller machine access. etc. It generates revenues from interest income from financial instruments and non-interest income and service charges on deposit accounts.

Share on Social Networks: